Mutational Model to Predict Response to Hypomethylating Agents (HMAs) in Myelodysplastic Syndromes (MDS)

Aziz Nazha; Tomas Radivoyevitch; Swapna Thota; Hetty E. Carraway; Bartlomiej Przychodzen; Matt Kalaycio; Mikkael A. Sekeres; Jaroslaw P. Maciejewski

doi:10.1016/j.clml.2015.07.091

Back

Mutational Model to Predict Response to Hypomethylating Agents (HMAs) in Myelodysplastic Syndromes (MDS)

Journal article

Peer reviewed

Mutational Model to Predict Response to Hypomethylating Agents (HMAs) in Myelodysplastic Syndromes (MDS)

Aziz Nazha, Tomas Radivoyevitch, Swapna Thota, Hetty E. Carraway, Bartlomiej Przychodzen, Matt Kalaycio, Mikkael A. Sekeres and Jaroslaw P. Maciejewski

Clinical lymphoma, myeloma and leukemia, Vol.15, pp.S43-S43

2015-09

DOI: https://doi.org/10.1016/j.clml.2015.07.091

Metrics

11 Record Views

Details

Title: Mutational Model to Predict Response to Hypomethylating Agents (HMAs) in Myelodysplastic Syndromes (MDS)
Creators: Aziz Nazha - Cleveland Clinic
Tomas Radivoyevitch - Cleveland Clinic
Swapna Thota - Cleveland Clinic
Hetty E. Carraway - Cleveland Clinic
Bartlomiej Przychodzen - Cleveland Clinic
Matt Kalaycio - Cleveland Clinic
Mikkael A. Sekeres - Cleveland Clinic
Jaroslaw P. Maciejewski - Cleveland Clinic
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.15, pp.S43-S43
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757874002976